Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Galapagos NV (GLPG)

$185.07 0.72 (0.39%)

17:28 EST GLPG Stock Quote Delayed 15 Minutes

Volume:

Previous Close $185.07

Market Cap 9.50B

PE Ratio -

EPS -

Volume (Avg. Vol.) 127,900

Day's Range 183.39 - 187.23

52-Week Range 85.00 - 192.89

Dividend & Yield N/A (N/A)

GLPG Stock Predictions, Articles, and Galapagos NV News

From InvestorPlace
From the Web

5 Biotech Stocks to Buy for a Strong Growth Prognosis

By Aaron Levitt, InvestorPlace Contributor Oct 25, 2019

The long term is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.

Nasdaq Today: Bitcoin & Libra; What’s Broadcom Doing?

By Bret Kenwell, InvestorPlace Contributor Jul 15, 2019

It was quiet for the Nasdaq today, but bitcoin, Facebook's Libra and the Broadcom-Symantec deal were in focus.

Galapagos Deal: GLPG Stock Rockets Higher on Gilead Stake

By William White, InvestorPlace Writer Jul 15, 2019

A Galapagos deal with Gilead that includes a collaboration and an investment in the company has GLPG stock heading higher on Monday.

5 Clinical-Stage Biotech Stocks to Buy

By Aaron Levitt, InvestorPlace Contributor Feb 25, 2019

There are plenty of potential in clinical-stage biotech stocks. Here are five with some wonderful catalysts.

5 Beaten-Down Biotech Stocks to Pick Up from the Wreckage

By Aaron Levitt, InvestorPlace Contributor Oct 17, 2018

After the market's rout, biotech stocks offer a huge value right now. Here are 5 that offer the best opportunities for investors.

Biggest Movers in Manufacturing Stocks Now – BSPM RTTR SCL CCXI

By Portfolio Grader Oct 18, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

Compare Brokers

Gilead Sciences, Inc. Is More Than an HCV Play (GILD)

By James Brumley, InvestorPlace Feature Writer Oct 12, 2016

Gilead Sciences (GILD) stock is a bargain at these prices. Traders just have yet to see the glass as half full.

The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing

From Benzinga Nov 14, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Nov. 13.) Antares Pharma Inc (...

The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher

From Benzinga Nov 13, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 12) ACADIA Pharmaceuticals...

5 Healthcare Stocks Moving In Monday's Pre-Market Session

From Benzinga Nov 11, 2019

Gainers Innate Pharma, Inc. (NASDAQ: IPHA) shares rose 3.8% to $6.55 during Monday's pre-market session. Teva Pharmaceutical Indus, Inc. (NYSE: TEVA) shares surged 2.8% to $9...

European Stocks Slip on China Concerns

From Barron's Nov 11, 2019

European stocks on Monday sagged on concerns over the progress of U.S.-China trade talks and violence in Hong Kong.

Europe Markets: Europe stocks sag on China trade and Hong Kong violence concerns

From Marketwatch Nov 11, 2019

European stocks on Monday sagged on concerns over the progress of U.S.-China trade talks and violence in Hong Kong.

Here's Why Galapagos Stock Rose 20.5% in October

From The Motley Fool Nov 7, 2019

The company reported third-quarter 2019 operating results and deepened its relationship with Gilead Sciences.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

A

Strong Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!